Overview

Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the hair growth response to topical NEOSH101 when applied twice daily to the balding scalp for 16 weeks. One hundred eighty men with Norwood/Hamilton grades III-IV with thinning in the top and center of the scalp will participate. Three equally sized treatment groups (60 men each) will receive either topical NEOSH101 2.0%, minoxidil 5%, or placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Neosil, Inc.
Treatments:
Proteasome Inhibitors